For pharmaceutical companies engaged in the production of antifungal medications, sourcing high-quality intermediates is paramount. One such crucial compound is cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol methanesulfonate, identified by its CAS number 67914-86-7. This intermediate plays a pivotal role in the complex synthesis of Itraconazole, a widely prescribed antifungal agent.

As a dedicated manufacturer and supplier based in China, we understand the stringent requirements of the pharmaceutical industry. Our commitment is to provide a reliable and consistent supply of pharmaceutical intermediates that meet exacting purity standards. The cis-mesylate intermediate we offer is characterized by its high purity (≥99%), ensuring that it effectively serves its purpose in the synthesis of Active Pharmaceutical Ingredients (APIs). We pride ourselves on being a trusted partner for pharmaceutical R&D and manufacturing sectors worldwide.

When considering the procurement of CAS 67914-86-7, it is essential to partner with a manufacturer that guarantees product integrity and a robust supply chain. Our production processes are designed to maintain the highest quality throughout, from raw material sourcing to final product packaging. This focus on quality control minimizes risks for our clients and ensures that their manufacturing processes run smoothly. For those looking to buy in bulk, we offer competitive pricing structures, making it economically viable to secure a steady supply for large-scale production.

Our role extends beyond simple supply; we aim to be an integral part of our clients' success. By providing essential building blocks like the cis-mesylate intermediate, we support the development and widespread availability of critical antifungal treatments. Whether you are conducting early-stage research, optimizing synthesis routes, or scaling up production, our team is equipped to meet your needs. We encourage you to reach out to us to discuss your specific requirements, obtain detailed technical specifications, and receive a competitive quote for this vital pharmaceutical intermediate.